NOVEL METHOD FOR PREPARING SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONIST

Organization Name

Inventor(s)

NOVEL METHOD FOR PREPARING SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONIST - A simplified explanation of the abstract

This abstract first appeared for US patent application 18555233 titled 'NOVEL METHOD FOR PREPARING SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONIST

Simplified Explanation: The patent application describes a new method for preparing a compound of chemical Formula 7, or a salt thereof, which can be used as a sphingosine-1-phosphate receptor agonist.

This innovation presents a novel method for synthesizing a specific compound.
The compound can act as an agonist for sphingosine-1-phosphate receptors.
The method allows for the efficient preparation of the compound or its salt.
The technology disclosed in the patent application has potential pharmaceutical applications.
The compound may have therapeutic benefits in the treatment of certain conditions.

Potential Applications: The technology could be applied in the pharmaceutical industry for the development of new drugs targeting sphingosine-1-phosphate receptors.

Problems Solved: This technology addresses the need for effective methods of synthesizing compounds with sphingosine-1-phosphate receptor agonist properties.

Benefits: The benefits of this technology include the potential for developing new pharmaceuticals with targeted receptor agonist activity.

Commercial Applications: The technology could have commercial applications in the pharmaceutical industry, leading to the development of new drugs with specific receptor agonist properties.

Questions about the Technology: 1. What are the potential therapeutic applications of compounds acting as sphingosine-1-phosphate receptor agonists? 2. How does this method for preparing compound Formula 7 differ from existing synthesis methods?

Original Abstract Submitted

The present invention relates to a novel method for preparing a compound of chemical Formula 7, or a salt thereof, which is disclosed in the present specification and can be effectively used as a sphingosine-1-phosphate receptor agonist.